sulfinpyrazone has been researched along with Mitral Stenosis in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BAssan, MM | 1 |
| Steele, PP | 1 |
| Weily, HS | 1 |
| Davies, H | 1 |
| Genton, E | 1 |
2 other studies available for sulfinpyrazone and Mitral Stenosis
| Article | Year |
|---|---|
Sulfinpyrazone, mitral stenosis and atrial fibrillation.
Topics: Atrial Fibrillation; Humans; Mitral Valve Stenosis; Sulfinpyrazone | 1981 |
Platelet survival in patients with rheumatic heart disease.
Topics: Adenosine Diphosphate; Aortic Valve Stenosis; Blood Platelets; Cell Survival; Chromium Radioisotopes | 1974 |